Home-based HPV self-sampling assisted by a cloud-based electronic data system: Lessons learnt from a pilot community cervical cancer screening campaign in rural Ethiopia.


Journal

Papillomavirus research (Amsterdam, Netherlands)
ISSN: 2405-8521
Titre abrégé: Papillomavirus Res
Pays: Netherlands
ID NLM: 101662552

Informations de publication

Date de publication:
06 2020
Historique:
received: 16 12 2019
revised: 23 04 2020
accepted: 27 04 2020
pubmed: 18 5 2020
medline: 7 4 2021
entrez: 17 5 2020
Statut: ppublish

Résumé

Primary HPV testing and triage of HPV-positive women is an effective cervical cancer screening strategy. Such a multi-visit screening algorithm is also promising for community-based screening in resource-poor communities, provided a robust tracking system is in place. A cervical cancer screening campaign was conducted in a rural community in Ethiopia. All women aged 25-65 years were offered genital self-sampling using the Evalyn Brush®. Samples were HPV-DNA-tested at a central laboratory. Key indicators were captured on tablet computers and linked by a cloud-based information system. HPV-positive women were examined at the local clinic using portable colposcopy, p16/Ki-67 dual stain cytology and biopsy examination. CIN2+ women were referred for LEEP to the referral hospital. Of 749 enumerated age-eligible women 634 (85%, (95% CI 82-88)) consented to screening, 429 samples were adequate for HPV testing, giving a total testing coverage of 57% (95% CI 53-62). The hrHPV prevalence was 14% (95% CI 5-22), 72% (95% CI 60-84) attended the clinic for a triage examination. Home-based HPV-DNA self-sampling and clinic-based triage assisted by cloud-based information technology is feasible in rural Ethiopia. Key components of such strategy are broad community awareness, high competency of community workers, and establishment of an adequate self-sampling and HPV-DNA testing platform.

Identifiants

pubmed: 32416283
pii: S2405-8521(20)30005-7
doi: 10.1016/j.pvr.2020.100198
pmc: PMC7240728
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

100198

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

BMJ. 2018 Dec 5;363:k4823
pubmed: 30518635
Trop Med Int Health. 2009 Oct;14(10):1287-302
pubmed: 19772550
BMC Womens Health. 2018 Jun 11;18(1):89
pubmed: 29890991
PLoS Med. 2008 Jun 17;5(6):e132
pubmed: 18563963
Papillomavirus Res. 2018 Jun;5:192-200
pubmed: 29689311
N Engl J Med. 2013 Jun 6;368(23):2149-52
pubmed: 23738542
Glob Health Sci Pract. 2016 Mar 25;4(1):87-98
pubmed: 27016546
Reprod Health. 2018 Dec 12;15(1):206
pubmed: 30541595
J Glob Oncol. 2016 Oct 12;3(5):635-657
pubmed: 29094101
Rev Obstet Gynecol. 2009 Fall;2(4):240-4
pubmed: 20111660
BMC Womens Health. 2018 Jul 3;18(1):116
pubmed: 29970063
Int J Gynaecol Obstet. 2018 Apr;141(1):63-69
pubmed: 29197067
Lancet Glob Health. 2015 Feb;3(2):e85-94
pubmed: 25617202
Int J Gynecol Cancer. 2014 Feb;24(2):339-45
pubmed: 24326529
Gynecol Oncol. 2017 Jan;144(1):51-56
pubmed: 28094038
Int J Gynaecol Obstet. 2013 Aug;122(2):118-23
pubmed: 23731506
J Clin Microbiol. 2008 Mar;46(3):1050-9
pubmed: 18199790
Cancer Causes Control. 2016 Oct;27(10):1253-9
pubmed: 27581249
Int J Gynecol Cancer. 2013 Mar;23(3):507-12
pubmed: 23354369
BMC Public Health. 2019 Jan 3;19(1):14
pubmed: 30606132
J Med Virol. 2020 Jan;92(1):113-118
pubmed: 31471920
J Glob Oncol. 2018 Sep;4:1-5
pubmed: 30241142
Trop Med Int Health. 2015 Oct;20(10):1355-67
pubmed: 26031572
Eur J Cancer. 2015 Nov;51(16):2375-85
pubmed: 26296294
Cancer Prev Res (Phila). 2019 Sep;12(9):609-616
pubmed: 31337647
BMC Cancer. 2013 Jan 02;13:2
pubmed: 23282173
JAMA Intern Med. 2019 Jul 1;179(7):881-888
pubmed: 31081870
Intervirology. 2019;62(3-4):124-133
pubmed: 31487743
BMJ Open. 2018 Jun 12;8(6):e020484
pubmed: 29895648
PLoS One. 2016 Jun 16;11(6):e0157217
pubmed: 27310005
Afr Health Sci. 2018 Sep;18(3):623-636
pubmed: 30602995
Prev Med. 2017 Aug;101:96-101
pubmed: 28579497
Int J Gynaecol Obstet. 2014 Jan;124(1):12-8
pubmed: 24140218
Virol J. 2019 Jul 23;16(1):92
pubmed: 31337408
Vaccine. 2013 Dec 29;31 Suppl 5:F53-9
pubmed: 24331748
Clinics (Sao Paulo). 2017 Mar;72(3):183-187
pubmed: 28355365
Sex Transm Dis. 2015 Nov;42(11):607-11
pubmed: 26462184
J Clin Virol. 2016 Mar;76 Suppl 1:S14-S21
pubmed: 26522865
Nature. 2015 Dec 3;528(7580):S77-85
pubmed: 26633769
Lancet. 2011 Nov 26;378(9806):1868-73
pubmed: 22051739
Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1434-8
pubmed: 22806169
J Community Health. 2014 Jun;39(3):409-15
pubmed: 24276617
Int J Cancer. 2020 Jul 1;147(1):128-138
pubmed: 31633801
BMC Public Health. 2019 May 29;19(Suppl 1):603
pubmed: 31138174
Int J Womens Health. 2015 Jul 31;7:765-72
pubmed: 26261427
Int J Gynaecol Obstet. 2016 Mar;132(3):259-65
pubmed: 26851054
Lancet Oncol. 2014 Feb;15(2):172-83
pubmed: 24433684
Glob Health Action. 2019;12(1):1587894
pubmed: 30938248
J Natl Cancer Inst. 2019 Sep 1;111(9):923-932
pubmed: 30629194
Int J Cancer. 2013 Dec 1;133(11):2681-7
pubmed: 23712523
Int J Gynecol Cancer. 2019 Jan;29(1):23-27
pubmed: 30640679
Int J Gynaecol Obstet. 2015 Mar;128(3):206-10
pubmed: 25468050
Int J Gynaecol Obstet. 2017 Jul;138 Suppl 1:33-40
pubmed: 28691330
BMJ Open. 2017 Oct 22;7(10):e015496
pubmed: 29061601
Glob Health Sci Pract. 2018 Jun 29;6(2):242-246
pubmed: 29959268
Pan Afr Med J. 2014 Mar 11;17:189
pubmed: 25396015
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
BMJ Glob Health. 2019 May 14;4(3):e001351
pubmed: 31179035
Asian Pac J Cancer Prev. 2014;15(20):8563-9
pubmed: 25374168
Gynecol Oncol. 2018 Jan;148(1):118-125
pubmed: 29153541
J Natl Cancer Inst. 2012 Feb 8;104(3):178-88
pubmed: 22271765

Auteurs

Felix Jede (F)

Applied Tumor Biology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany. Electronic address: felix@jede.name.

Theresa Brandt (T)

Applied Tumor Biology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany. Electronic address: theresa-brandt@gmx.net.

Molla Gedefaw (M)

Amhara Regional Health Bureau, Bahir Dar, Ethiopia. Electronic address: bdfam72@gmail.com.

Solomon Berhe Wubneh (SB)

Department of Obstetrics and Gynecology, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. Electronic address: solomonbe2310@gmail.com.

Tamrat Abebe (T)

Department of Microbiology, Immunology and Parasitology, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia. Electronic address: tamrat.abebe@aau.edu.et.

Brhanu Teka (B)

Department of Microbiology, Immunology and Parasitology, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia. Electronic address: brhanu.teka@aau.edu.et.

Kassahun Alemu (K)

Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. Electronic address: kassalemu@gmail.com.

Binyam Tilahun (B)

Department of Health Informatics, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. Electronic address: binigcms@gmail.com.

Temesgen Azemeraw (T)

Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. Electronic address: tazemeraw@gmail.com.

Abebaw Gebeyehu (A)

Amhara Regional Health Bureau, Bahir Dar, Ethiopia. Electronic address: gabebaw2worku@gmail.com.

Dietmar Schmidt (D)

Department of Cytopathology, Institute of Pathology, Viersen, Germany. Electronic address: dischmi57@gmail.com.

Aleksandra Pesic (A)

Clinic for Gynecology, Charité - Berlin Institute of Health, Charite - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Campus Benjamin Franklin, Berlin, Germany. Electronic address: aleksandra.pesic@charite.de.

Andreas M Kaufmann (AM)

Clinic for Gynecology, Charité - Berlin Institute of Health, Charite - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Campus Benjamin Franklin, Berlin, Germany. Electronic address: andreas.kaufmann@charite.de.

Bewketu Abebe (B)

Department of Pathology, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. Electronic address: dischmi57@gmail.com.

Zelalem Ayichew (Z)

Department of Obstetrics and Gynecology, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. Electronic address: zelalem538@yahoo.com.

Michael Byczkowski (M)

SAP SE, Walldorf, Germany. Electronic address: michael.byczkowski@sap.com.

Timoté Vaucher (T)

École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland. Electronic address: timote.vaucher@epfl.ch.

Heike Sartor (H)

Applied Tumor Biology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany. Electronic address: heike.sartor@med.uni-heidelberg.de.

Gashaw Andargie (G)

Department of Health Systems and Policy, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. Electronic address: gashawab@gmail.com.

Till Bärnighausen (T)

Heidelberg Institute of Global Health (HIGH), Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany; Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, USA; Africa Health Research Institute (AHRI), Somkhele and Durban, South Africa. Electronic address: till.baernighausen@uni-heidelberg.de.

Magnus von Knebel Doeberitz (M)

Applied Tumor Biology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany. Electronic address: magnus.knebel-doeberitz@med.uni-heidelberg.de.

Hermann Bussmann (H)

Applied Tumor Biology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany. Electronic address: Hermann.Bussmann@med.uni-heidelberg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH